| answer text |
<p>The Commission on Human Medicines Expert Working Group on Hormone Pregnancy Tests
was established in 2015 to consider all the available evidence on the possible association
between exposure in pregnancy to hormone pregnancy tests and adverse outcomes in pregnancy.
The Expert Working Group conducted a comprehensive, scientifically robust and independent
review of all available scientific evidence relating to hormone pregnancy tests including
the responses to a public call for evidence. In reaching its conclusion that, taking
all aspects into consideration, the available evidence did not support a causal association
between the use of hormone pregnancy tests during early pregnancy, the Expert Working
Group made a number of forward-looking recommendations to further strengthen the scientific
evidence which supports safety monitoring of medicines in pregnancy. The current focus
of the Medicines and Healthcare products Regulatory Agency (MHRA) is on implementing
these recommendations.</p><p>The Government’s priority, as always, is the safety of
patients. While there are no plans to fund independent scientific research into hormone
pregnancy tests (which have not been available since 1978), should any further evidence
emerge of direct relevance to hormone pregnancy tests the MHRA will evaluate this.
In addition, certain recommendations of the Expert Working Group’s review are anticipated
to encourage relevant research into the safety of medicines in pregnancy.</p><p><strong>
</strong></p>
|
|
